Yubo International Biotech Limited (YBGJ) Fair Value 2026

YBGJ · Medical Instruments & Supplies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.5 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (42/100)

Quick Summary — As of 2026-08-27, Yubo International Biotech Limited (YBGJ) trades at $0.01. QOC: 4.5/10. Value Trap Risk: 42/100 (WARN). 0/13 models active.

Key Facts

Ticker
YBGJ
Price
$0.01
Quality Score
4.5/10
Value Trap Risk
42/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 42 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give YBGJ?

0 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Yubo International Biotech Limited (YBGJ) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Yubo International Biotech Limited currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About YBGJ?

0 of 13 models are currently active for YBGJ. See which stocks rank higher →

How Does YBGJ Rank in Medical Instruments & Supplies?

Among 55 Medical Instruments & Supplies stocks, YBGJ ranks #49 by Quality of Company score. CirclFi's QOC score of 4.5/10 evaluates 32 fundamental signals. A score of 4.5 reflects mixed fundamentals.

See all Most Undervalued Medical Instruments & Supplies Stocks →

Yubo International Biotech Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is YBGJ a Value Trap?

CirclFi's Value Trap algorithm assigns YBGJ a score of 42/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Yubo International Biotech Limited. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Yubo International Biotech Limited earns a quality score of 4.5/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every YBGJ valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Yubo International Biotech Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Instruments & Supplies Stocks Should You Also Analyze?

11 related Medical Instruments & Supplies stocks with 13-model coverage

DXRDaxor CorporationQOC 4.6RGNTRegentis Biomaterials Ltd.QOC 4.3PLSEPulse Biosciences, Inc.QOC 5.3UEECUnited Health Products, Inc.QOC 4.1ZTEKZentek Ltd.QOC 5.4TUTHStandard Dental Labs Inc.QOC 3.2COOThe Cooper Companies, Inc.QOC 8.5SOLVSolventum CorporationQOC 7.2MLSSMilestone Scientific Inc.QOC 6.2ISRGIntuitive Surgical, Inc.QOC 9.4RMDResMed Inc.QOC 9.4

Read investment analysis: DXR · RGNT · PLSE · UEEC · ZTEK · TUTH · COO · SOLV · MLSS · ISRG · RMD

Which Other Stocks Have a Similar Quality Score to YBGJ?

7 companies across all industries closest to YBGJ’s Quality of Company score of 4.5/10.

DFLIDragonfly Energy Holdings Corp.QOC 4.6GABThe Gabelli Equity Trust Inc.QOC 4.5ATXIAvenue Therapeutics, Inc.QOC 4.6PMNProMIS Neurosciences, Inc.QOC 4.5QPRCQuest Patent Research CorporationQOC 4.6CRWECrown Equity Holdings Inc.QOC 4.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: DFLI · GAB · ATXI · PMN · QPRC · CRWE · NVDA

Where Does YBGJ Sit in CirclFi's Medical Instruments & Supplies Rankings?

YBGJ is ranked against every other Medical Instruments & Supplies stock CirclFi covers in each of these screens.

See all Medical Instruments & Supplies stocks ranked →

What Else Do Investors Ask About Yubo International Biotech Limited’s Valuation?

What is Yubo International Biotech Limited's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Yubo International Biotech Limited (YBGJ). The Quality of Company score is 4.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is YBGJ overvalued or undervalued right now?

At $0.01, 0 of 0 active models suggest YBGJ may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Yubo International Biotech Limited's business model in Medical Instruments & Supplies.

What does a Quality of Company score of 4.5 mean for YBGJ?

Yubo International Biotech Limited's QOC of 4.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on YBGJ?

CirclFi analyzes YBGJ with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is YBGJ a value trap in 2026?

Yubo International Biotech Limited's Value Trap score is 42/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Yubo International Biotech Limited (YBGJ) a Quality of Company score of 4.5/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/YBGJ/ · Methodology
Primary sources for this YBGJ valuation
  • Financial statements: Yubo International Biotech Limited 10-K and 10-Q filings on SEC EDGAR (CIK 0000895464) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for YBGJ as of ; valuations recomputed .